Pfizer Warns of Inhaled Insulin Lung Cancer Risk
April 9th, 2008 at 10:58 am (Diabetes, Insulin, Medicine and Health, Pfizer Inc|PFE|NYSE)
Pfizer and Nektar Therapeutics said clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to abandon the troubled product.
Zrodlo (oryginalny wpis) na http://www.nytimes.com/reuters/business/business-pfizer-nektar.html?ex=1365480000&en=0aa5f20acd076967&ei=5088&partner=rssnyt&emc=rss,By REUTERS